Trial NCT05432804

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2022-05066
Secondary IDs: 10505 NCI-2022-05066 PHII-222 UM1CA186717

Last trial update was posted on 2024-04-18

MeSH Interventions

Temozolomide

MeSH Conditions

Glioblastoma Recurrence

Other Conditions

MGMT-Methylated Glioblastoma Recurrent Glioblastoma, IDH-Wildtype Recurrent MGMT-Methylated Glioblastoma

Stopping Reasons

End of Initial Phase of Multi-phase protocol

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID